Needham, MA, February 02, 2013 --(PR.com
)-- Molecular Medicine Tri-Conference has announced that free exhibit hall and keynote presentation passes are now available for the 2013 exhibition, taking place February 13-14 in San Francisco, CA. Attracting more than 3,000 scientific professionals annually, the event equips teams with the latest developments in Molecular Medicine, including Diagnostics, Informatics, Clinical Research, Therapeutics, Cancer Research and Partnering.
The complimentary exhibit hall pass provides visitors with access to:
- 150 Exhibiting Organizations
- 90+ Scientific Poster Displays
- Vendor Theater Presentations
- New Product Showcase, featuring the first showing of 30+ new technologies
- Networking Reception
- “Personalized Oncology – Fulfilling the Promise for Today's Patients”
Keynote Presentation, Moderated by Marty Tenenbaum, Ph.D., Founder and Chairman, Cancer Commons; Prominent AI Researcher; Cancer Survivor
- “Emerging Technologies & Industry Perspectives”
Panel Discussion, Moderated by Harry Glorikian, Managing Partner, Scientia
- “Implementing the Rapid-Learning Healthcare System for Cancer Care”
Panel Discussion, Moderated by Marcia Kean, Chairman, Strategic Initiatives,
Feinstein Kean Healthcare
New for 2013, visitors also gain admission to their choice of 45 interactive breakout sessions, providing the opportunity to discuss pressing questions across specialized topics, such as: End to End Companion Diagnostics Development; Implementing Pharmacogenomics; Changing the Face of Diagnostics in Healthcare and Bioinformatics for Clinical Genome Sequencing.
Complimentary hall passes are available until Friday, February 1, 2013. Reserve yours today at http://www.triconference.com/hallpass
About Molecular Medicine Tri-Conference
Cambridge Healthtech Institute's flagship event, Molecular Medicine Tri-Conference is the leading drug discovery research event covering a broad spectrum of cutting-edge topics within molecular medicine with scientific, business and regulatory viewpoints. Spanning five days, the Tri-Conference includes 5 Concurrent Symposia, the Emerging Molecular Diagnostics Partnering Forum, 15 Afternoon & Dinner Short Courses, 15 Conference Programs and a two-day exhibition.
About Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.